🇺🇸 FDA
Drug

cemiplimab-rwlc

Brand: LIBTAYO

approved

Quick answer

cemiplimab-rwlc (LIBTAYO), is a pharmaceutical active ingredient, associated with REGENERON PHARMACEUTICALS, INC., with approved status in the US.

Key facts

INN
cemiplimab-rwlc
Brand
LIBTAYO
Route
INTRAVENOUS
Formulation
INJECTABLE
Originator
REGENERON PHARMACEUTICALS, INC.

Frequently asked questions

What is cemiplimab-rwlc?

cemiplimab-rwlc (LIBTAYO), is a pharmaceutical active ingredient, associated with REGENERON PHARMACEUTICALS, INC., with approved status in the US.

What is the brand name for cemiplimab-rwlc?

LIBTAYO is a marketed brand name for cemiplimab-rwlc. Check FDA Drugs@FDA for the current US label holder.